Antimicrobial peptides of the genus Bacillus: a new era for antibiotics CD Sumi, BW Yang, IC Yeo, YT Hahm Canadian journal of microbiology 61 (2), 93-103, 2015 | 450 | 2015 |
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis T Mestrovic, GR Aguilar, LR Swetschinski, KS Ikuta, AP Gray, ND Weaver, ... The Lancet Public Health 7 (11), e897-e913, 2022 | 200 | 2022 |
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram‑Negative Bacteria? A Systematic Review CD Sumi, AJ Heffernan, J Lipman, JA Roberts, FB Sime Clinical Pharmacokinetics, 2019 | 147 | 2019 |
Implantable microchip: the futuristic controlled drug delivery system KB Sutradhar, CD Sumi Drug delivery 23 (1), 1-11, 2016 | 97 | 2016 |
Evaluation of Antidiarrheal Activity of Methanolic Extract of Maranta arundinacea Linn. Leaves MK Rahman, MAU Chowdhury, MT Islam, MA Chowdhury, ME Uddin, ... Advances in Pharmacological and Pharmaceutical Sciences 2015 (1), 257057, 2015 | 83 | 2015 |
Evaluation of antinociceptive activity of hydromethanol extract of Cyperus rotundus in mice MZ Imam, CD Sumi BMC complementary and alternative medicine 14, 1-5, 2014 | 71 | 2014 |
The burden and trend of diseases and their risk factors in Australia, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. GBDA Collaborators Lancet Public Health 8 (8), e585-e599, 2023 | 29 | 2023 |
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae CD Sumi, H Aaron J, S Naicker, K Islam, K Cottrell, SC Wallis, J Lipman, ... Journal of Antimicrobial Chemotherapy, 10.1093/jac/dkaa211, 2020 | 15 | 2020 |
RNA-Seq Analysis of Antibiotic-Producing Bacillus subtilis SC-8 Reveals a Role for Small Peptides in Controlling PapR Signaling BW Yang, IC Yeo, JH Choi, CD Sumi, YT Hahm Applied Biochemistry and Biotechnology, 2017 | 3 | 2017 |
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli … CD Sumi, H Aaron J, S Naicker, K Cottrell, SC Wallis, J Lipman, ... Journal of Antimicrobial Chemotherapy, https://doi.org/10.1093/jac/dkac273, 2022 | 2 | 2022 |
Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of PandrugResistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective … MJ Hasan, CD Sumi, SMR Huq, AM Anam, R Rabbani The Journal of Critical Care Medicine, 2023 | 1 | 2023 |
Quantification of levetiracetam in plasma and urine and its application to a pharmacokinetic study of traumatic brain injury patients SKS Adiraju, CD Sumi, S Pandey, MO Cotta, JA Roberts, J Lipman, ... Bioanalysis 15 (1), 31-42, 2023 | 1 | 2023 |
COVID-19 drug treatments are prone to sequestration in extracorporeal membrane oxygenation circuits: an ex vivo ECMO study JA Dhanani, K Shekar, D Parmar, J Lipman, D Bristow, SC Wallis, H Won, ... ASAIO Journal, DOI: 10.1097/MAT.0000000000002120, 2023 | | 2023 |
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae … CD Sumi, JA Roberts, FB Sime Journal of Antimicrobial Chemotherapy, https://doi.org/10.1093/jac/dkad017, 2023 | | 2023 |
Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study... Australian and New Zealand … M Cree, E Haisz, C Sumi, S Wallis, L Schlapbach, J Roberts, S Parker | | 2023 |
Are meropenem, piperacillin, tazobactam and vancomycin sequestered onto a paediatric extracorporeal membrane oxygenation circuit? An ex vivo study M Cree, E Haisz, C Sumi, S Wallis, L Schlapbach, J Roberts, S Parker Australian Critical Care 36, S5-S6, 2023 | | 2023 |
Does renal replacement therapy impact the clearance of meropenem, piperacillin, tazobactam and vancomycin in a critically ill child? An ex vivo study M Cree, L Schlapbach, C Sumi, S Wallis, J Roberts, S Parker Australian Critical Care 36, S4-S5, 2023 | | 2023 |
Pharmacokinetics of Polymyxin B and the Pharmacokinetic/pharmacodynamic target attainment in Hospitalised Adult Patients with Multidrug-resistant Gram-negative Infections PJ Zamri, MH Abdul-Aziz, MP Hernández-Mitre, MS Hasan, IM Shariff, ... The 32nd European Congress of Clinical Microbiology & Infectious Diseases, 2022 | | 2022 |
60: PHARMACOKINETICS OF POLYMYXIN B AND THE PHARMACOKINETIC/PHARMACODYNAMIC TARGET ATTAINMENT IN HOSPITALISED ADULT PATIENTS WITH MULTIDRUG-RESISTANT GRAM-NEGATIVE INFECTIONS M Puteri Juanita Zamri, D Mohd-Hafiz Abdul-Aziz, ... | | 2022 |
A validated UHPLC-MS/MS method for the quantification of remdesivir and its metabolite GS-441524 in human plasma CD Sumi, SC Wallis, S Pandey, H Won, A Stewart, J Dhanani, J Lipman, ... Queensland Mass Spectrometry Symposium (QMSS), Gold Coast, Australia, 2021 | | 2021 |